Tatsuo Yamaguchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tatsuo Yamaguchi has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Masahiro Fujimuro
Department of Cell Biology, Kyoto Pharmaceutical University
4 shared publications - Tadashi Watanabe
Department of Virology, Graduate school of medicine, University of the Ryukyus
4 shared publications - Yuki Iwaisako
Department of Cell Biology, Kyoto Pharmaceutical University
3 shared publications - Fatemeh Mohammadipanah
Pharmaceutical Biotechnology Lab, School of Biology and Center of Excellence in Phylogeny of Living Organisms, College of Science, University of Tehran, Tehran, Iran
1 shared publication - Firoozeh Piroozmand1 shared publication
- Fumihiro Kato
Department of Virology III National Institute of Infectious Diseases Tokyo Japan
1 shared publication
Latest Publications
- Open Access
- 4 November 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 48
Structure-based binding pocket conservation analysis identifies 9-OH urolithin dehydroxylase candidates across phylogenetically diverse bacteria
- 4 November 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 48
Open AccessStructure-based binding pocket conservation analysis identifies 9-OH urolithin dehydroxylase candidates across phylogenetically diverse bacteria
- 30 June 2026
- Published by Elsevier in Experimental Cell Research
- Vol. 461 (2) , 115121
Extracellular release of cytotoxic aggregates from HSV-1-replicating SH-SY5Y cells: involvement of alpha-synuclein and poly-ubiquitin conjugates
- 30 June 2026
- Published by Elsevier in Experimental Cell Research
- Vol. 461 (2) , 115121
Extracellular release of cytotoxic aggregates from HSV-1-replicating SH-SY5Y cells: involvement of alpha-synuclein and poly-ubiquitin conjugates
- Open Access
- 25 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (11) , 4750
Graph and Hypergraph Theories Applied to Dynamic Protein–Protein Interaction Network Analysis, and Deep-Learning Frameworks for Protein Complex Network Prediction
Protein interactions form large-scale networks known as protein–protein interaction networks (PPINs) or protein complex networks (PCNs). Extracting meaningful structural frameworks from these molecular relationships through mathematical modeling enables a deeper understanding of biological processes. Although static protein network models have provided valuable insights into the organization of PPINs, they are limited in their ability to capture the dynamic and cooperative nature of protein complexes. This review begins by introducing fundamental concepts in graph and hypergraph theory, with an emphasis on centrality measures. We then discuss the evolution of PPIN analysis from static representations to dynamic graph- and hypergraph-based frameworks. Specifically, we review dynamic PPINs and the challenges associated with their interpolation, dynamic centrality measures, and network models capable of representing multi-node relationships that have been applied to PPINs. Finally, we highlight recent advances in machine learning and deep learning approaches that integrate interaction data with functional annotations, sequence information, and cellular context to predict novel interactions and reconstruct transient protein complexes. Taken together, dynamic PPIN modeling combined with experimental validation provides an integrated framework for understanding coordinated protein functions in cellular processes and across biological systems as well as supporting drug development.
- 25 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (11) , 4750
Open AccessGraph and Hypergraph Theories Applied to Dynamic Protein–Protein Interaction Network Analysis, and Deep-Learning Frameworks for Protein Complex Network Prediction
Protein interactions form large-scale networks known as protein–protein interaction networks (PPINs) or protein complex networks (PCNs). Extracting meaningful structural frameworks from these molecular relationships through mathematical modeling enables a deeper understanding of biological processes. Although static protein network models have provided valuable insights into the organization of PPINs, they are limited in their ability to capture the dynamic and cooperative nature of protein complexes. This review begins by introducing fundamental concepts in graph and hypergraph theory, with an emphasis on centrality measures. We then discuss the evolution of PPIN analysis from static representations to dynamic graph- and hypergraph-based frameworks. Specifically, we review dynamic PPINs and the challenges associated with their interpolation, dynamic centrality measures, and network models capable of representing multi-node relationships that have been applied to PPINs. Finally, we highlight recent advances in machine learning and deep learning approaches that integrate interaction data with functional annotations, sequence information, and cellular context to predict novel interactions and reconstruct transient protein complexes. Taken together, dynamic PPIN modeling combined with experimental validation provides an integrated framework for understanding coordinated protein functions in cellular processes and across biological systems as well as supporting drug development.
- Open Access
- 7 February 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 2022
Sofosbuvir Suppresses the Genome Replication of DENV1 in Human Hepatic Huh7 Cells
Dengue virus (DENV) causes dengue fever and dengue hemorrhagic fever, and DENV infection kills 20,000 people annually worldwide. Therefore, the development of anti-DENV drugs is urgently needed. Sofosbuvir (SOF) is an effective drug for HCV-related diseases, and its triphosphorylated metabolite inhibits viral RNA synthesis by the RNA-dependent RNA polymerase (RdRp) of HCV. (2′R)-2′-Deoxy-2′-fluoro-2′-methyluridine (FMeU) is the dephosphorylated metabolite produced from SOF. The effects of SOF and FMeU on DENV1 replication were analyzed using two DENV1 replicon-based methods that we previously established. First, a replicon-harboring cell assay showed that DENV1 replicon replication in human hepatic Huh7 cells was decreased by SOF but not by FMeU. Second, a transient replicon assay showed that DENV1 replicon replication in Huh7 cells was decreased by SOF; however, in hamster kidney BHK-21 cells, it was not suppressed by SOF. Additionally, the replicon replication in Huh7 and BHK-21 cells was not affected by FMeU. Moreover, we assessed the effects of SOF on infectious DENV1 production. SOF suppressed infectious DENV1 production in Huh7 cells but not in monkey kidney Vero cells. To examine the substrate recognition of the HCV and DENV1 RdRps, the complex conformation of SOF-containing DENV1 RdRp or HCV RdRp was predicted using AlphaFold 2. These results indicate that SOF may be used as a treatment for DENV1 infection.
- 7 February 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 2022
Open AccessSofosbuvir Suppresses the Genome Replication of DENV1 in Human Hepatic Huh7 Cells
Dengue virus (DENV) causes dengue fever and dengue hemorrhagic fever, and DENV infection kills 20,000 people annually worldwide. Therefore, the development of anti-DENV drugs is urgently needed. Sofosbuvir (SOF) is an effective drug for HCV-related diseases, and its triphosphorylated metabolite inhibits viral RNA synthesis by the RNA-dependent RNA polymerase (RdRp) of HCV. (2′R)-2′-Deoxy-2′-fluoro-2′-methyluridine (FMeU) is the dephosphorylated metabolite produced from SOF. The effects of SOF and FMeU on DENV1 replication were analyzed using two DENV1 replicon-based methods that we previously established. First, a replicon-harboring cell assay showed that DENV1 replicon replication in human hepatic Huh7 cells was decreased by SOF but not by FMeU. Second, a transient replicon assay showed that DENV1 replicon replication in Huh7 cells was decreased by SOF; however, in hamster kidney BHK-21 cells, it was not suppressed by SOF. Additionally, the replicon replication in Huh7 and BHK-21 cells was not affected by FMeU. Moreover, we assessed the effects of SOF on infectious DENV1 production. SOF suppressed infectious DENV1 production in Huh7 cells but not in monkey kidney Vero cells. To examine the substrate recognition of the HCV and DENV1 RdRps, the complex conformation of SOF-containing DENV1 RdRp or HCV RdRp was predicted using AlphaFold 2. These results indicate that SOF may be used as a treatment for DENV1 infection.
- 17 March 2023
- Published by SPIE-Intl Soc Optical Eng
- Vol. PC12360, PC1236006-5
Lissajous OCT angiography for large field-of-view, high-dense spatial sampling, and long-duration microvasculature imaging
OCT-based angiography (OCTA) enables imaging of retinal microvasculature. However, involuntary movements of subjects prevent obtaining microvasculature with a large field of view (FOV) with high-dense spatial sampling. Meanwhile, a short duration for blood flow detection results in unstable vasculature contrast. By combining a Lissajous scan and a slow shift, Lissajous OCT enables compensating eye movements, and then the FOV will be extended while the spatial sampling density is preserved by the slow shift. The Lissajous scan allows a long blood flow detection duration. In vivo human eye microvasculature imaging using the convolutional Lissajous OCTA is investigated with several disease eyes.
- 17 March 2023
- Published by SPIE-Intl Soc Optical Eng
- Vol. PC12360, PC1236006-5
Lissajous OCT angiography for large field-of-view, high-dense spatial sampling, and long-duration microvasculature imaging
OCT-based angiography (OCTA) enables imaging of retinal microvasculature. However, involuntary movements of subjects prevent obtaining microvasculature with a large field of view (FOV) with high-dense spatial sampling. Meanwhile, a short duration for blood flow detection results in unstable vasculature contrast. By combining a Lissajous scan and a slow shift, Lissajous OCT enables compensating eye movements, and then the FOV will be extended while the spatial sampling density is preserved by the slow shift. The Lissajous scan allows a long blood flow detection duration. In vivo human eye microvasculature imaging using the convolutional Lissajous OCTA is investigated with several disease eyes.
- Open Access
- 8 January 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (2) , 1238
Kaposi’s Sarcoma-Associated Herpesvirus ORF21 Enhances the Phosphorylation of MEK and the Infectivity of Progeny Virus
Kaposi’s sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus-8, is the causative agent of Kaposi’s sarcoma, Castleman’s disease, and primary effusion lymphoma. Although the functions of the viral thymidine kinases (vTK) of herpes simplex virus-1/2 are well understood, that of KSHV ORF21 (an ortholog of vTK) is largely unknown. Here, we investigated the role of ORF21 in lytic replication and infection by generating two ORF21-mutated KSHV BAC clones: ORF21-kinase activity deficient KSHV (21KD) and stop codon-induced ORF21-deleted KSHV (21del). The results showed that both ORF21 mutations did not affect viral genome replication, lytic gene transcription, or the production of viral genome-encapsidated particles. The ORF21 molecule-dependent function, other than the kinase function of ORF21, was involved in the infectivity of the progeny virus. ORF21 was expressed 36 h after the induction of lytic replication, and endogenously expressed ORF21 was localized in the whole cytoplasm. Moreover, ORF21 upregulated the MEK phosphorylation and anchorage-independent cell growth. The inhibition of MEK signaling by U0126 in recipient target cells suppressed the number of progeny virus-infected cells. These suggest that ORF21 transmitted as a tegument protein in the progeny virus enhances the new infection through MEK up-regulation in the recipient cell. Our findings indicate that ORF21 plays key roles in the infection of KSHV through the manipulation of the cellular function.
- 8 January 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (2) , 1238
Open AccessKaposi’s Sarcoma-Associated Herpesvirus ORF21 Enhances the Phosphorylation of MEK and the Infectivity of Progeny Virus
Kaposi’s sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus-8, is the causative agent of Kaposi’s sarcoma, Castleman’s disease, and primary effusion lymphoma. Although the functions of the viral thymidine kinases (vTK) of herpes simplex virus-1/2 are well understood, that of KSHV ORF21 (an ortholog of vTK) is largely unknown. Here, we investigated the role of ORF21 in lytic replication and infection by generating two ORF21-mutated KSHV BAC clones: ORF21-kinase activity deficient KSHV (21KD) and stop codon-induced ORF21-deleted KSHV (21del). The results showed that both ORF21 mutations did not affect viral genome replication, lytic gene transcription, or the production of viral genome-encapsidated particles. The ORF21 molecule-dependent function, other than the kinase function of ORF21, was involved in the infectivity of the progeny virus. ORF21 was expressed 36 h after the induction of lytic replication, and endogenously expressed ORF21 was localized in the whole cytoplasm. Moreover, ORF21 upregulated the MEK phosphorylation and anchorage-independent cell growth. The inhibition of MEK signaling by U0126 in recipient target cells suppressed the number of progeny virus-infected cells. These suggest that ORF21 transmitted as a tegument protein in the progeny virus enhances the new infection through MEK up-regulation in the recipient cell. Our findings indicate that ORF21 plays key roles in the infection of KSHV through the manipulation of the cellular function.
- Open Access
- 25 November 2022
- Published by MDPI AG in Preprints.org
Kaposi’s Sarcoma-associated Herpesvirus ORF21 Enhances the Phosphorylation of MEK and the Infectivity of Progeny Virus
Kaposi’s sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus-8, is the causative agent of Kaposi’s sarcoma, Castleman’s disease, and primary effusion lymphoma. Although the functions of the viral thymidine kinases (vTK) of herpes simplex virus-1/2 and varicella zoster virus are well understood, that of KSHV ORF21 (an ortholog of vTK) is largely unknown. Here, we investigated the role of ORF21 in lytic replication and infection by generating two ORF21-mutated KSHV BAC clones: ORF21-kinase activity deficient-KSHV (21KD) and stop codon-induced ORF21-deleted-KSHV (21del). The results showed that both ORF21-mutations did not affect viral genome replication, lytic genes transcription, or the production of viral genome-encapsidated particles. ORF21 molecule-dependent function, other than the kinase function of ORF21, was involved in the infectivity of progeny virus. ORF21 was expressed at 36 h after induction of lytic replication, and endogenously expressed ORF21 was localized in the whole cytoplasm and decreased on the cell surface area. Moreover, the effects of ORF21 expression on signaling pathways and proliferation were analyzed. The results showed that ORF21 upregulated the MEK phosphorylation and anchorage-independent cell growth. These findings indicate that ORF21 plays key roles in both infection and oncogenesis of KSHV through the manipulation of cellular function.
- 25 November 2022
- Published by MDPI AG in Preprints.org
Open AccessKaposi’s Sarcoma-associated Herpesvirus ORF21 Enhances the Phosphorylation of MEK and the Infectivity of Progeny Virus
Kaposi’s sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus-8, is the causative agent of Kaposi’s sarcoma, Castleman’s disease, and primary effusion lymphoma. Although the functions of the viral thymidine kinases (vTK) of herpes simplex virus-1/2 and varicella zoster virus are well understood, that of KSHV ORF21 (an ortholog of vTK) is largely unknown. Here, we investigated the role of ORF21 in lytic replication and infection by generating two ORF21-mutated KSHV BAC clones: ORF21-kinase activity deficient-KSHV (21KD) and stop codon-induced ORF21-deleted-KSHV (21del). The results showed that both ORF21-mutations did not affect viral genome replication, lytic genes transcription, or the production of viral genome-encapsidated particles. ORF21 molecule-dependent function, other than the kinase function of ORF21, was involved in the infectivity of progeny virus. ORF21 was expressed at 36 h after induction of lytic replication, and endogenously expressed ORF21 was localized in the whole cytoplasm and decreased on the cell surface area. Moreover, the effects of ORF21 expression on signaling pathways and proliferation were analyzed. The results showed that ORF21 upregulated the MEK phosphorylation and anchorage-independent cell growth. These findings indicate that ORF21 plays key roles in both infection and oncogenesis of KSHV through the manipulation of cellular function.
- 20 June 2012
- Published by Optica Publishing Group in Optics Letters
- Vol. 37 (13) , 2496-2498
Adaptive optics dioptric scanning ophthalmoscope with a wider field of view similar to those of normal ophthalmoscopes
We introduce a newly developed adaptive optics dioptric scanning ophthalmoscope (AO-DSO) in which all powered optical parts were refractive lenses instead of concave or convex mirrors. By designing dioptric optics, we were able to achieve a compact instrument with a 10 deg field of view (FOV10) and 1.5 deg field of view (FOV1.5) high-resolution imaging. Although the resolution of FOV10 was sacrificed because of the variation of aberrations of the eye over the 10 deg field, our system works with AO in the case of FOV1.5 and can be used as a scanning laser ophthalmoscope with good optical slicing in the case of FOV10. To test the ability of the AO-DSO, we performed imaging on a normal subject and on a patient with occult macular dystrophy.
- 20 June 2012
- Published by Optica Publishing Group in Optics Letters
- Vol. 37 (13) , 2496-2498
Adaptive optics dioptric scanning ophthalmoscope with a wider field of view similar to those of normal ophthalmoscopes
We introduce a newly developed adaptive optics dioptric scanning ophthalmoscope (AO-DSO) in which all powered optical parts were refractive lenses instead of concave or convex mirrors. By designing dioptric optics, we were able to achieve a compact instrument with a 10 deg field of view (FOV10) and 1.5 deg field of view (FOV1.5) high-resolution imaging. Although the resolution of FOV10 was sacrificed because of the variation of aberrations of the eye over the 10 deg field, our system works with AO in the case of FOV1.5 and can be used as a scanning laser ophthalmoscope with good optical slicing in the case of FOV10. To test the ability of the AO-DSO, we performed imaging on a normal subject and on a patient with occult macular dystrophy.